Cargando…

Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients

CA19-9 is a tumor-associated antigen. It is also a marker of pancreatic tissue damage that might be caused by diabetes. Long-term poor glycemic control may lead to pancreatic beta cell dysfunction which is reflected by elevated serum CA19-9 level. Intracellular cholesterol accumulation leads to isle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Haoyong, Li, Ruixia, Zhang, Lei, Chen, Haibing, Bao, Yuqian, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384953/ https://www.ncbi.nlm.nih.gov/pubmed/22778715 http://dx.doi.org/10.1155/2012/745189

Ejemplares similares

Decreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass
por: Tu, Yinfang, et al.
Publicado: (2014)

Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy
por: Huang, Yan, et al.
Publicado: (2012)

A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
por: Chen, Haibing, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients
por: Zhang, Lei, et al.
Publicado: (2016)

Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
por: Li, Xu, et al.
Publicado: (2017)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
por: Chen, Yu-Ling, et al.
Publicado: (2013)

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer
por: Ko, A H, et al.
Publicado: (2005)

Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy
por: Guo, Kaifeng, et al.
Publicado: (2015)

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials
por: Maisey, N R, et al.
Publicado: (2005)

Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
por: Guo, Kaifeng, et al.
Publicado: (2015)

Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma
por: Li, Xu, et al.
Publicado: (2017)

A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
por: Wu, Mian, et al.
Publicado: (2017)

Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
por: Zhu, Ruirui, et al.
Publicado: (2015)

Colorectal Carcinoma with Extremely Low CA19-9
por: Kawamura, Yutaka J., et al.
Publicado: (2009)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy
por: Bernhard, J, et al.
Publicado: (2010)

Associations between serum clusterin levels and non-alcoholic fatty liver disease
por: Wang, Yansu, et al.
Publicado: (2023)

Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels
por: Zhou, Sanshun, et al.
Publicado: (2019)

Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus
por: Wang, Shenqi, et al.
Publicado: (2013)

Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y Gastric Bypass in Chinese obese patients with BMI 28–35 kg/m(2) and Type 2 diabetes: a 6-month follow-up
por: Tu, Yinfang, et al.
Publicado: (2015)

Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
por: Ermiah, Eramah, et al.
Publicado: (2022)

Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population
por: Luo, Yuqi, et al.
Publicado: (2015)

Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
por: Ni, Jie, et al.
Publicado: (2013)

Serum A-FABP Is Increased and Closely Associated with Elevated NT-proBNP Levels in Type 2 Diabetic Patients Treated with Rosiglitazone
por: Zhou, Mi, et al.
Publicado: (2011)

The Predictivity of Serum Biochemical Markers in Acute Biliary Pancreatitis
por: Güngör, Bülent, et al.
Publicado: (2011)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Serum Concentrations of Transforming Growth Factor-Beta 1 in Predicting the Occurrence of Diabetic Retinopathy in Juvenile Patients with Type 1 Diabetes Mellitus
por: Zorena, Katarzyna, et al.
Publicado: (2013)

Association between Serum Uric Acid Levels and Diabetes Mellitus
por: Bandaru, Pavani, et al.
Publicado: (2011)

Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
por: Martinelli, Nicola, et al.
Publicado: (2012)

Serum CA(19-9) in patients with solid pancreatic mass
por: Baghbanian, Mahmud, et al.
Publicado: (2013)

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.
por: Lundin, J., et al.
Publicado: (1994)

Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma
por: Zhao, J., et al.
Publicado: (2016)

Serum TNF-Alpha Level Predicts Nonproliferative Diabetic Retinopathy in Children
por: Zorena, Katarzyna, et al.
Publicado: (2007)

Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy
por: Zhang, Fanliang, et al.
Publicado: (2021)

Prevalence of Type 2 Diabetes among High-Risk Adults in Shanghai from 2002 to 2012
por: Wang, Congrong, et al.
Publicado: (2014)

Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood
por: Peticca, Patricia, et al.
Publicado: (2013)

Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
por: Dong, Dong, et al.
Publicado: (2018)

Hyperuricemia and overexcretion of uric acid increase the risk of simple renal cysts in type 2 diabetes
por: Han, Ying, et al.
Publicado: (2017)

The Nonlinear Relationship Between Psoas Cross-sectional Area and BMI: A New Observation and Its Insights Into Diabetes Remission After Roux-en-Y Gastric Bypass
por: Li, Shaobo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amq28l0nup8i91r86lgt244fiv